<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="114387">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02009267</url>
  </required_header>
  <id_info>
    <org_study_id>IRB13-00702</org_study_id>
    <nct_id>NCT02009267</nct_id>
  </id_info>
  <brief_title>Nuss Procedure: Clinical Options in Pediatric Pain Management?</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ralph Beltran</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nationwide Children's Hospital</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A retrospective chart review study analyzing the benefits of patient controlled analgesia,
      thoracic epidural analgesia, and paravertebral nerve block catheters in patients having
      surgical repair of pectus excavatum using the Nuss procedure.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>November 2013</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Retrospective</study_design>
  <primary_outcome>
    <measure>Total morphine dose</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 3 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Total morphine dose will be evaluated in mg/kg/24 hour period, beginning with post-op day 0 until discharge from the hospital.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score</measure>
    <time_frame>Participants will be followed for the duration of hospital stay, an expected average of 3 days</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain scores obtained from the visual analog scale.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of hospitalization</measure>
    <time_frame>Within the first week after surgery.</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determine if there is a difference in length of hospitalization, and time to discharge.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nausea and vomiting</measure>
    <time_frame>0-48 hrs. post-op</time_frame>
    <safety_issue>No</safety_issue>
    <description>Determine the incidence of nausea and vomiting measured by the postoperative ondansetron dosing, beginning with arrival to floor and up to the first 48 hrs of hospitalization.</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Pectus Excavatum</condition>
  <arm_group>
    <arm_group_label>Patient controlled analgesia</arm_group_label>
    <description>Use of patient controlled analgesia (PCA) for the management of postoperative pain after the Nuss procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous thoracic epidural infusion</arm_group_label>
    <description>Continuous thoracic epidural infusions (TE) for the management of postoperative pain after the Nuss procedure.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Continuous paravertebral blockade</arm_group_label>
    <description>Continuous paravertebral blockade (PVB) for the management of postoperative pain after the Nuss procedure.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Patient controlled analgesia</intervention_name>
    <description>A programable electronically controlled infusion pump that delivers an amount of intravenous analgesic when the patient presses a button.</description>
    <arm_group_label>Patient controlled analgesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous thoracic epidural infusions</intervention_name>
    <description>Continuous thoracic epidural infusions (TE) involves continuous infusion of drugs through a catheter placed into the epidural space, resulting in a loss of sensation—including the sensation of pain—by blocking the transmission of signals through nerve fibers in or near the spinal cord.</description>
    <arm_group_label>Continuous thoracic epidural infusion</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Continuous paravertebral blockade</intervention_name>
    <description>Continuous paravertebral blockade (PVB) is the technique of injecting local anesthetic adjacent to the thoracic vertebra that anesthetizes the spinal nerve roots after they exit the spinal canal.</description>
    <arm_group_label>Continuous paravertebral blockade</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing the Nuss procedure to correct pectus excavatum at Nationwide
        Children's Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients undergoing the NUSS procedure since the beginning of 2011 to Sept. 30th,
             2013.

        Exclusion Criteria:

          -  None
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Beltran Ralph, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nationwide Children's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Nationwide Children's Hospital</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2013</verification_date>
  <lastchanged_date>December 6, 2013</lastchanged_date>
  <firstreceived_date>November 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Nationwide Children's Hospital</investigator_affiliation>
    <investigator_full_name>Ralph Beltran</investigator_full_name>
    <investigator_title>Assistant Clinical Professor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Funnel Chest</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
